# A Trial of Varenicline for E-cigarette Cessation

> **NCT07040566** · PHASE2 · RECRUITING · sponsor: **Yale University** · enrollment: 326 (estimated)

## Conditions studied

- E-cigarette Use
- Vaping
- Nicotine Dependence

## Interventions

- **DRUG:** Varenicline 1mg BID
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07040566
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-14
- **Primary completion:** 2030-07-30
- **Final completion:** 2030-10-30
- **Target enrollment:** 326 (ESTIMATED)
- **Last updated:** 2025-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07040566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07040566, "A Trial of Varenicline for E-cigarette Cessation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07040566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*